Biblio
.
Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia. Am Soc Clin Oncol Educ Book. 2023;43:e390010.
. [NK cells: a major role in the antitumoral immunomodulation in CML]. Med Sci (Paris). 2018;34(6-7):540-546.
.